Canadian industrial technology firm EnWave has bagged a contract from Bonduelle to increase the productivity of the latter’s 120kW Radiant Energy Vacuum (REV) machinery. Bonduelle is a French based global processor of frozen ...
Tags: Energy Vacuum, REV Machiney
EnWave announced that it has signed a technology Evaluation and License Option Agreement (TELOA) with Born Wild, a seafood processor located in the US. Born Wild plans to develop dried seafood snack applications processed by the company's ...
Tags: Seafood, EnWave Technology
EnWave announced that it has signed a Technology Evaluation and License Option Agreement (the TELOA) with a major European food processor (the Research Partner). The agreement has been signed to explore the potential for dried meat ...
Tags: EnWave, REV Technology
EnWave has signed a technology evaluation and license option agreement with a vertically-integrated, leading table grape producer in California. The Agreement grants the GP the exclusive right to develop crispy grape snack applications ...
Tags: agriclutural products, fruits, grape
Japanese pharmaceutical firm PeptiDream and France-based Ipsen have expanded their research collaboration and license option agreement signed in April 2013 to develop peptide drugs to treat serious endocrinologic disease. The deal has now ...
Tags: PeptiDream, Ipsen, peptide drugs
Domain Therapeutics SA announced today that Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting ...
Tags: Domain Therapeutics SA, chemical, drugs
The research collaboration will leverage Mucosis' Mimopath platform technology in Crucell's program for developing undisclosed novel vaccines to combat infectious diseases. Mucosis CEO Thomas Johnston said Mimopath platform combined ...
Tags: License Option Agreement, biotechnology, novel vaccines